Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of an SMS Reminder on Influenza Vaccination Coverage in Patients With Rheumatoid Arthritis Taking Anti-TNF : an Ancillary Study to the French National Registry ART E-cohort

NCT05220423 is registered in ClinicalTrials.gov with Societe Francaise de Rhumatologie as lead sponsor.

NCT NCT05220423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05220423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of an SMS Reminder on Influenza Vaccination Coverage in Patients With Rheumatoid Arthritis Taking Anti-TNF : an Ancillary Study to the French National Registry ART E-cohort
Lead sponsor
Societe Francaise de Rhumatologie
Phase
Not applicable
Overall status
Completed
Start date
October 19, 2021
Completion date
April 30, 2022
Enrollment
446 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis